ArticleVirology journal2026
Host-specificity assessment of feline alphaherpesvirus-1 derived immunocontraceptive candidates in non-feline models.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Veterinarian attitudes towards immunocontraceptive use in cats.Australian veterinary journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Feline alphaherpesvirus-1 (FHV-1) is generally considered to have a narrow host range restricted to the Felidae family. As a result, FHV-1 has been proposed as a potential vaccine vector to carry foreign pathogen or immunocontraceptive antigens, for use in domestic cat (Felis catus) populations. The species-specificity of FHV-1 has been described previously in the 1970s where several non-feline hosts were assessed for their inability to be infected by FHV-1. However, more recently, evidence of FHV-1 infection in BALB/c mice was reported, furthering the need for additional investigation into the host range potential of FHV-1. This study investigated the species-specificity of FHV-1 and three modified FHV-1 variants containing antigens intended as immunocontraceptive targets. Their ability to replicate in respiratory tissue, cause clinical signs and induce disruptions in female reproductive tissues was studied in an in vivo murine model. Furthermore, a diverse range of non-feline cell types originating from species including domestic animals, wildlife species and a non-human primate were also investigated for their ability to support FHV-1 immunocontraceptive replication in vitro. No evidence of FHV-1 replication was detected in vitro in the non-feline cell lines, nor was any evidence of disruption to female reproductive tissues or viral activity detected in the murine model. The findings contribute towards the global understanding of FHV-1 host range and add support for its use as a feline-specific viral vector.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.